The Future of Sunscreens: A Shift Away from Chemical UV Filters
- Geoff Acton
- Nov 28
- 3 min read
Sunscreen science is undergoing a major transformation. As evidence grows around hormone disruption, systemic absorption, and environmental toxicity from certain chemical UV filters, regulators and brands are accelerating a shift toward mineral, non-nano zinc oxide — a UV filter with decades of safety data and global regulatory acceptance.

A Growing Regulatory Divide
Around the world, regulatory agencies have taken stronger action, reassessing older chemical filters, such as 4-MBC (4-methylbenzylidene camphor):
European Union: Following a comprehensive safety review, the EU introduced a phase-out of 4-MBC in cosmetic products starting 1/5/2025, with a ban taking effect on 1/5/2026.
United States: The FDA determined that 4-MBC does not meet GRASE standards for use in sunscreens.
Global landscape: 4-MBC is now banned in 29 countries, reflecting a broad consensus built on toxicological and endocrine-disruption data.
Meanwhile, the TGA’s earlier position — set out in its 2005 internal file note advising no urgent action — has not kept pace with the decisions made in comparable regulatory environments. Australia still permits its use at up to 4%, including in children’s sunscreens.
4-MBC is only one example. Other chemical filters, such as oxybenzone, homosalate, and octocrylene are experiencing similar scrutiny. The direction of travel is clear: regulators are moving away from chemical absorbers with questionable safety profiles.
Why Zinc Oxide Is the Future of UV Protection
As chemical filters face bans and restrictions, zinc oxide has emerged as the most secure, evidence-backed UV active for the next generation of sunscreens. Its advantages are increasingly aligned with both science and public expectations.
True Broad-Spectrum Coverage: Zinc oxide is the only single active ingredient that blocks the full UVA and UVB spectrum, including deep UVA1 — the wavelengths most linked to melanoma and skin ageing.
Proven Long-Term Safety: It remains on the skin’s surface, does not disrupt hormones, and avoids the breakdown by-products associated with some organic filters.
Regulatory Stability Worldwide: Zinc oxide is approved by every major regulatory authority — FDA, TGA, EU SCCS, Japan, ASEAN — giving brands confidence to formulate for global markets.
Consumer Trust and Market Momentum: Demand for mineral sunscreens continues to grow among parents, dermatologists, and health-conscious consumers seeking non-absorbing, non-irritating, and environmentally safe options.
A Forward-Looking Ingredient for Modern Formulation: As more chemical UV filters undergo safety reassessment, zinc oxide stands out as the only UV filter whose regulatory position is strengthening rather than weakening.
Technical Summary (Evidence-Based Overview)
4-MBC has been identified as an endocrine-active UV filter with documented effects on oestrogenic and thyroid pathways. It has been detected in human breast milk, confirming systemic absorption. After extensive safety evaluation, the European Union enacted a full ban through Commission Regulation (EU) 2024/996 of 3 April 2024, which states:
“From 1 May 2025 products containing that substance shall not be placed on the Union market. From 1 May 2026 cosmetic products containing that substance shall not be made available on the Union market.”
The U.S. FDA separately concluded in 2015 that 4-MBC does not meet GRASE criteria, eliminating its use in American sunscreens. Globally, 4-MBC is banned in 29 countries.
In contrast, non-nano zinc oxide remains one of the few UV filters consistently recognised across all major regulatory jurisdictions as safe, photostable, non-hormonal, and environmentally compatible. Optical studies confirm uniform attenuation across UVB, UVA2, and UVA1 wavelengths — a level of performance that many chemical filters fail to achieve due to photodegradation or spectral gaps.
This evidence underpins zinc oxide’s position as the most future-proof UV filter for next-generation sunscreen innovation.
References
European Commission. (2024). Commission Regulation (EU) 2024/996 of 3 April 2024 amending Regulation (EC) No 1223/2009 of the European Parliament and of the Council as regards the use of Vitamin A, Alpha-Arbutin and Arbutin and certain substances with potential endocrine disrupting properties in cosmetic products. Official Journal of the European Union, L(996), 1–8. http://data.europa.eu/eli/reg/2024/996/oj

.png)



Comments